Israeli company ChroniSense Medical received FDA 510(k) clearance for its Polso wearable that collects and shares vital signs via a mobile app for patients and a cloud-based platform for clinicians.
The wrist-worn wearable enables clinicians to monitor patients' vitals, including blood oxygen saturation (SpO2), pulse rate and respiration rate. The company touts the watch as ideal for remote...
